Related Experiment Video
Updated: Jun 24, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway
Man Jiang1, Cong-Yi Wang, Shuang Huang
1Department of Cellular Biology and Anatomy, Medical College of Georgia, 1459 Laney Walker Blvd., Augusta, GA 30912, USA.
Abstract:
Nephrotoxicity is the major limiting factor for the use of cisplatin in cancer therapy. Recent studies have demonstrated an important role for p53 in cisplatin-induced renal injury. Nevertheless, pharmacological and genetic blockade of p53 only provides partial renoprotective effects, suggesting the presence of p53-independent injury mechanisms. To understand the p53-independent mechanisms, we have now examined cisplatin-induced apoptosis in p53-deficient kidney cells. We show that cisplatin could induce Bax activation, cytochrome c release, and apoptosis in primary cultures of p53-deficient renal tubular cells, albeit at a level that was lower than in the wild-type cells. Cisplatin could also induce typical apoptosis in p53-deficient baby mouse kidney (BMK) cells. The apoptosis was caspase dependent and could be completely blocked by general caspase inhibitors. Bax and Bak, two key molecules in the mitochondrial pathway of apoptosis, were interdependently activated by cisplatin, with Bax translocation to and Bax/Bak oligomerization in mitochondria, leading to cytochrome c release. Importantly, cytochrome c release and apoptosis were diminished in Bax/Bak single or double-knockout BMK cells. Furthermore, overexpression of Bcl-2 could ameliorate cisplatin-induced cytochrome c release and apoptosis. Together, the results have demonstrated a p53-independent mechanism of cisplatin nephrotoxicity that involves the mitochondrial pathway of apoptosis.
Insights
Cisplatin causes kidney damage through p53-independent pathways. This involves the mitochondrial apoptosis pathway, even without functional p53, highlighting new targets for preventing cisplatin nephrotoxicity.
Area of Science:
- Nephrology
- Molecular Biology
- Cancer Therapy
Background:
- Cisplatin is a vital chemotherapy drug, but its use is limited by kidney toxicity (nephrotoxicity).
- The tumor suppressor protein p53 plays a role in cisplatin-induced kidney injury, but blocking it only partially protects the kidneys.
- This suggests that p53-independent mechanisms contribute to cisplatin nephrotoxicity.
Purpose of the Study:
- To investigate the p53-independent mechanisms of cisplatin-induced kidney cell apoptosis.
- To elucidate the role of the mitochondrial pathway in cisplatin nephrotoxicity.
Main Methods:
- Examined cisplatin-induced apoptosis in p53-deficient primary renal tubular cells and baby mouse kidney (BMK) cells.
- Utilized caspase inhibitors, Bax/Bak knockout BMK cells, and Bcl-2 overexpression.
- Assessed Bax activation, cytochrome c release, and apoptosis.
Main Results:
- Cisplatin induced apoptosis in p53-deficient kidney cells via a caspase-dependent mitochondrial pathway.
- Bax and Bak activation, mitochondrial translocation, and oligomerization were critical for cytochrome c release and apoptosis.
- Inhibition of Bax/Bak or overexpression of Bcl-2 reduced cisplatin-induced apoptosis.
Conclusions:
- A p53-independent mechanism contributes to cisplatin nephrotoxicity.
- The mitochondrial apoptosis pathway, involving Bax and Bak, is a key player in this p53-independent injury.
- Targeting the mitochondrial pathway may offer novel strategies for preventing cisplatin-induced kidney damage.
Related Concept Videos
The Intrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Inhibition of Cdk Activity
The Extrinsic Apoptotic Pathway

